Key terms

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CDXS news

May 03 7:38am ET Benchmark Co. Sticks to Their Buy Rating for Codexis (CDXS) by TipRanks May 02 5:07pm ET Codexis files $200M mixed securities shelf by TipRanks May 02 5:06pm ET Codexis sees gross margin 58%- 63%, excluding revenue related to PAXLOVID by TipRanks May 02 5:03pm ET Codexis reports Q1 EPS (16c), consensus (18c) by TipRanks Apr 26 7:50am ET Codexis (CDXS) Gets a Buy from Piper Sandler by TipRanks Apr 11 7:11am ET Codexis appoints Carole Cobb to strategic advisory board by TipRanks Mar 01 11:04am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 01 7:48am ET Piper Sandler Sticks to Their Buy Rating for Codexis (CDXS) by TipRanks Mar 01 1:00am ET A New Cause for Concern: Codexis Adds a New Corporate Activity and Growth Risk by TipRanks Feb 29 9:55am ET Codexis upgraded to Buy at Benchmark after Q4 revenue and 2024 guidance by TipRanks Feb 29 9:34am ET Codexis upgraded to Buy from Hold at Benchmark by TipRanks Feb 29 8:19am ET Stifel Nicolaus Keeps Their Buy Rating on Codexis (CDXS) by TipRanks Feb 28 10:20pm ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (BFLY) and Codexis (CDXS) by TipRanks Feb 26 4:19pm ET Codexis, Roche in licensing deal for newly engineered double-sranded DNA Ligase by TipRanks Feb 26 9:06am ET Craig-Hallum Gives a Buy Rating to Codexis (CDXS) by TipRanks Feb 20 8:17am ET Codexis appoints Damha, Lalonde to strategic advisory board by TipRanks Feb 13 4:42pm ET Codexis enters $40M loan facility agreement with Innovatus by TipRanks Feb 13 4:35pm ET Codexis Secures Strategic Financing to Support Growth Initiatives by TipRanks

No recent press releases are available for CDXS

CDXS Financials

1-year income & revenue

Key terms

CDXS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CDXS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse
Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half